(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 0.09% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Embecta's revenue in 2024 is $1,122,400,000.On average, 1 Wall Street analysts forecast EMBC's revenue for 2024 to be $64,485,109,522, with the lowest EMBC revenue forecast at $64,485,109,522, and the highest EMBC revenue forecast at $64,485,109,522. On average, 1 Wall Street analysts forecast EMBC's revenue for 2025 to be $64,388,549,671, with the lowest EMBC revenue forecast at $64,388,549,671, and the highest EMBC revenue forecast at $64,388,549,671.
In 2026, EMBC is forecast to generate $65,363,015,330 in revenue, with the lowest revenue forecast at $65,363,015,330 and the highest revenue forecast at $65,363,015,330.